NCT03476746View on ClinicalTrials.gov

Dermatopharmacokinetic Trial of LEO 90100 Foam

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Healthy
Interventions
DRUG

LEO 90100 foam

A foam formulation of the active comparator Dovobet® ointment

DRUG

Dovobet® ointment

Ointment formulation containing same active ingredients as LEO 90100 foam

Trial Locations (1)

812-0025

Investigational site, Fukuoka

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT03476746 - Dermatopharmacokinetic Trial of LEO 90100 Foam | Biotech Hunter | Biotech Hunter